Latest Manufacturing News

Hazer Group has filed patents for a breakthrough graphite purification process that could unlock access to the lucrative battery materials market amid tightening global supply. This innovation positions Hazer to meet surging demand for high-purity graphite essential for lithium-ion batteries.

Southern Cross Electrical Engineering has announced over $110 million in new and renewed contracts, reinforcing its position in Australia’s infrastructure services and manufacturing sectors.

Green360 Technologies has successfully raised A$4 million through a share placement to fund the commercialisation and scaling of its innovative low-carbon cement technology, supported by institutional investors and strengthened leadership.

PM Capital Global Opportunities Fund Limited reported a robust 33.98% rise in profit after tax to $168.2 million for FY25, alongside a raised fully franked final dividend of 6.0 cents per share. The fund’s portfolio outperformed key benchmarks, reflecting strategic positioning amid structural global economic changes.

ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.

Metro Performance Glass is set to strengthen its balance sheet and support its turnaround strategy through a $15 million to $24 million equity raise, with Amari Metals Australia poised to become the majority shareholder. This recapitalisation aims to reduce debt and improve operational focus amid challenging market conditions.

Metro Performance Glass proposes a $15–24 million recapitalisation involving a discounted rights offer and a major placement to Amari Metals, who would become the controlling shareholder.

The Calmer Co. has secured a long-term lease for its Navua facility in Fiji, replacing a planned property purchase and freeing up capital to accelerate its US market expansion.

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.

Orbital Corporation has denied any undisclosed information behind its recent share price jump, attributing market interest to strategic leadership appointments aimed at expanding its UAV propulsion business.

Memphasys Limited pivots from development to commercial execution with its flagship IVF product Felix, targeting global markets through direct sales and recurring revenue streams.